Universal Ibogaine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Universal Ibogaine generated cash of -$3,249,729, which is less than the previous year. Cash used in financing activities reached the amount of $3,382,273 last year. Net change in cash is therefore $89,615.
Cash Flow
| 2018 | -320.34K | -225K | 209.51K |
|---|---|---|---|
| 2020 | -121.98K | -26.52K | 16.08K |
| 2021 | -3.24M | -42.92K | 3.38M |
IBO.V Cash Flow Statement (2018 – 2021)
| 2021 | 2020 | 2018 | |
|---|---|---|---|
Cash at beginning of period | 52.58K | 204.92K | 387.75K |
Operating activities | |||
Net income | -3.86M | -118.30K | -408.28K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 69.85K | 255 | 0 |
Stock-based compensation expense | 0 | 0 | 94K |
| Deferred income tax benefit | 0 | 0 | 94K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | -5.81K | -27.76K |
Inventories | 0 | 0 | 0 |
Accounts payable | 279.91K | 0 | 0 |
Cash generated by operating activities | -3.24M | -121.98K | -320.34K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -1.52K | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -42.92K | -26.52K | -225K |
Financing activities | |||
Common Stock Issued | 3.34M | 0 | 209.51K |
Payments for dividends | -410K | 0 | 0 |
Repurchases of common stock | -46.45K | 0 | 0 |
Repayments of term debt | -123.4K | 0 | 0 |
Cash used in financing activities | 3.38M | 16.08K | 209.51K |
Net Change In Cash | 89.61K | -132.42K | -335.82K |
Cash at end of period | 142.19K | 72.5K | 51.92K |